Can 18F-Fluoroestradiol positron emission tomography become a new imaging standard in the estrogen receptor-positive breast cancer patient: A prospective comparative study with 18F-Fluorodeoxyglucose positron emission tomography?

Correct staging is the most crucial for the treatment outcome in cancer management. Molecular imaging with 18F-fluoroestradiol (FES) positron emission tomography-computed tomography (PET-CT) targets estrogen receptor (ER) and may have a higher incremental value in diagnosis by aiding specificity. We...

Descripció completa

Dades bibliogràfiques

Autors principals:	Manoj Gupta, Anupama Datta, Partha Choudhury, Maria Dsouza, Ullas Batra, Anil Mishra
Format:	Artigo
Idioma:	Inglês
Publicat:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2017-04-01
Col·lecció:	World Journal of Nuclear Medicine
Matèries:	18f-fluorodeoxyglucose positron emission tomography-computed tomography 18f-fluoroestradiol positron emission tomography-computed tomography diagnostic strength estrogen receptor-positive breast cancer incremental value
Accés en línia:	http://www.thieme-connect.de/DOI/DOI?10.4103/1450-1147.203071
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!